In one paragraphArticle in Journal for immunotherapy of cancer, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
9 authors.
Xueling WangShanghai Key Lab of Reproduction and Development, Shanghai Key Lab of Female Reproductive Endocrine Related Diseases, Obstetrics and Gynecology Hospital of Fudan University, Shanghai, China.ORCID http://orcid.org/0009-0005-8342-3969 Tian ChenShanghai Key Lab of Reproduction and Development, Shanghai Key Lab of Female Reproductive Endocrine Related Diseases, Obstetrics and Gynecology Hospital of Fudan University, Shanghai, China.ORCID http://orcid.org/0009-0004-8459-9045 Zehua WangShanghai Key Lab of Reproduction and Development, Shanghai Key Lab of Female Reproductive Endocrine Related Diseases, Obstetrics and Gynecology Hospital of Fudan University, Shanghai, China.ORCID http://orcid.org/0000-0003-2890-272X Chenyang WangShanghai Key Lab of Reproduction and Development, Shanghai Key Lab of Female Reproductive Endocrine Related Diseases, Obstetrics and Gynecology Hospital of Fudan University, Shanghai, China.ORCID http://orcid.org/0009-0007-6895-4897 Xuyao XuShanghai Key Lab of Reproduction and Development, Shanghai Key Lab of Female Reproductive Endocrine Related Diseases, Obstetrics and Gynecology Hospital of Fudan University, Shanghai, China.ORCID http://orcid.org/0009-0009-0993-5017 Moran YangShanghai Key Lab of Reproduction and Development, Shanghai Key Lab of Female Reproductive Endocrine Related Diseases, Obstetrics and Gynecology Hospital of Fudan University, Shanghai, China.ORCID http://orcid.org/0000-0002-0601-9090 Guodong ZhangShanghai Key Lab of Reproduction and Development, Shanghai Key Lab of Female Reproductive Endocrine Related Diseases, Obstetrics and Gynecology Hospital of Fudan University, Shanghai, China liuhaiou@fudan.edu.cn huangyan1168@aliyun.com gdzhang12@fudan.edu.cn.ORCID http://orcid.org/0000-0002-9297-1335 Yan HuangDepartment of Gynecologic Oncology, Fudan University Shanghai Cancer Center, Shanghai, China liuhaiou@fudan.edu.cn huangyan1168@aliyun.com gdzhang12@fudan.edu.cn.ORCID http://orcid.org/0000-0001-8811-7462 Haiou LiuShanghai Key Lab of Reproduction and Development, Shanghai Key Lab of Female Reproductive Endocrine Related Diseases, Obstetrics and Gynecology Hospital of Fudan University, Shanghai, China liuhaiou@fudan.edu.cn huangyan1168@aliyun.com gdzhang12@fudan.edu.cn.ORCID http://orcid.org/0000-0003-0200-8981 Funding
No grant is acknowledged in the PubMed record.
6 · The paper itselfAbstract
PubMed holds no abstract for this paper.
Indexed as
Immune Checkpoint InhibitorOvarian CancerTumor microenvironment - TME
What OpenQuestion holds
Textmetadata
Read underepoch 390